Search Results - Hamid Rezvani

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer by Shirin Kianersi, Sina Salari, Hamid Rezvani, Mohammad A Araskhan, Alireza Shirangi, Mohammad R Fathi, Mahmoud D Ghorbi

Connect to this object online.

Associations of the Healthy Beverage Index (HBI) and the risk of Breast Cancer (BrCa): a case-control study by Navideh Khodadadi, Mohammad Hassan Sohouli, Mojtaba Ghadiani, Hamid Rezvani, Mahdi Tabarraee, Hamid Reza Ahadi, Sina Salari, Hamide Rahmani Seraji

Connect to this object online.

Thoracic Sarcoma: A New Glance at the Epidemiological Characteristics of Disease in Iran from 2009 to 2014 by Hamide Rahmani Seraji, Mohmmad Esmaeil Akbari, Hamid Rezvani, Davood Bashash, Maryam Mabani, Atieh Akbari, Alireza Raeisi, Ghasem Janbabee, Sina Salari

Connect to this object online.

Post-Marketing Surveillance of a generic Oxaliplatin (AlvoxalⓇ) in Iranian Patients with Cancer by Farhad Shahi, Mojtaba Gorji, Assistant Professor of Pediatric Oncology, Mehrdad Payandeh, Assistant Professor of Hematology & Oncology, Hamid Rezvani, Associate Professor of Hematology & Oncology, Mohammad Vaezi, Associate Professor of Hematology & Oncology, Sharareh Seifi, Assistant Professor of Hematology & Oncology, Alireza Baari, Post doctoral fellowship, Reza Khalili-Dizaji, Post doctoral fellowship, Seyed Mehdi Hashemi, Associate Professor of Hematology & Oncology, Saeid Salimi, post doctoral fellowship, Hosein Kamranzadeh, Associate Professor of Hematology & Oncology, Babak Shazad, Post doctoral fellowship, Sina Salari, Associate Professor of Hematology & Oncology, Davoud Oulad Dameshghi, Assistant Professor of Hematology & Oncology, Mehdi Sarkheil, Post doctoral fellowship, Mehrzad Mirzania, Associate Professor of Hematology & Oncology, Nassim Anjidani, Pharm. D.

Connect to this object online.